Extended-spectrum β-lactamase and AmpC β-lactamase Production among Gram-negative Bacilli Isolates Obtained from Urinary Tract Infections and Wound Infections

Extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases continue to be a major problem in healthcare settings. Due to the scarcity of information regarding the antibiotic susceptibility patterns particularly from urinary tract infection (UTI) and wound infections, the current study was carried out to assist the clinicians to prescribe appropriate antibiotics against Gram-negative clinical isolates. In the current study, urine (n = 620) and pus (n = 228) samples were collected from different sites (at various clinical departments) and subjected to direct microscopic examination, culture and antibiotic susceptibility testing (AST). In the AST testings, the isolates that exhibited reduced zone of inhibition to one or more of the antibiotics such as cefotaxime (≤27 mm), ceftriaxone (≤25 mm), ceftazidime (≤22 mm), cefpodoxime (≤17 mm) and aztreonam (≤27 mm) were considered as potential ESBL producers and the ESBL production was confirmed using phenotypic screening test (double-disk synergy test) and phenotypic confirmatory test (combined-disk test). However, isolates showing resistance or decreased sensitivity to cefoxitin, cefotaxime, ceftriaxone, ceftazidime, cefpodoxime or aztreonam and sensitive to cefepime were considered as a screen positive AmpC producer and subjected to AmpC disk tests. The current study concluded that 72.41% and 21.76% of ESBL and AmpC producers were detected, respectively in our hospital. It was also observed that the double-disk synergy and combined-disk tests were equally effective for ESBL detection. Further, AmpC disk test is simple, easy to perform and interpret, requiring less expertise for the rapid detection of AmpC isolates

Antibacterial and Antibiofilm Properties of Medicinal Plant Extracts against Multi Drug Resistant Staphylococcus Species and Non Fermenter Bacteria

Antimicrobial resistance to the pathogenic microorganism has been characterized as a public health emergency both in the community and in hospitals. That is why; we need to find alternatives, which could be used as antibacterial agents. Therefore aim of this study is to determine the antibacterial and antibiofilm properties of 4 plant extracts Clove (Syzygium aromaticum), Tea (Camellia sinensis), Garlic (Allium sativum), coriander (Coriandrum sativum).Antibacterial properties of plant extracts at different concentrations (50, 25, 12.5, 6.25 mg/mL) were tested against Multi Drug Resistance biofilm producing Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus epidermidis and Staphylococcus saprophyticus using the agar well diffusion method.Minimum Bactericidal Concentration (MBC) and antibiofilm properties of the plant extracts were determined using the tube dilution method and modified crystal violet assay, respectively. Total of 180 clinical isolates were screened for their MDR Pattern. Out of these, 72 were MDR isolates. These MDR isolates were categorized into weak, moderate and strong biofilm producers. Fourteen, Forty nine and nine were weak, moderate and strong biofilm producers, respectively. Out of the 4 plant extracts, Syzygium aromaticum and Camellia sinensis were found to be more effective with maximum zone of inhibition (20 – 25 mm), MBC 6.25 mg/ml and biofilm reduction of more than 50% compared to Allium sativum and Coriandrum sativum. All medicinal plant extracts were effective at different concentrations against the biofilm producing MDR isolates but Syzygium aromaticum and Camellia sinensis showed maximum antibacterial and antibiofilm activity